Three of the four major inhaler manufacturers have announced plans to cap patient copays for all ... Administration’s ...
Hosted on MSN10mon
Senator slams GlaxoSmithKline over cost of asthma inhalersLess than two months after GlaxoSmithKline pledged to cap out-of-pocket costs for its inhalers at $35 a month ... review patents listed in the FDA’s Orange Book — a registry of drugs approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results